FIELD: chemistry.
SUBSTANCE: invention relates to the field of biotechnology, namely to the application of a conjugate of an immunogenic peptide and can be used in medicine. The said conjugate, containing 1÷93 of immunogenic peptides Aβ(35-42) (SEQ ID NO: 2), or 1÷93 of immunogenic peptides Aβ(33-42) (SEQ ID NO: 3), or 1÷93 of immunogenic peptides Aβ(33-40) (SEQ ID NO: 4), connected with a native albumin by means of a linker region, containing cysteine and a bifunctional linker, on condition that the linker region is connected by means of cysteine to the N-end of not more than one immunogenic peptide, can be used for the application in treatment or prevention of a disease, associated with the deposit of amyloid proteins. The invention also relates to the application of a pharmaceutical composition, containing the said conjugate, for the treatment or prevention of the disease, associated with the deposit of the amyloid proteins.
EFFECT: invention makes it possible to efficiently reduce levels of the amyloid peptide with the application of a simple in obtaining structure of the immunogenic peptide conjugate.
9 cl, 8 dwg, 7 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS OF PEPTIDE CONJUGATE AND METHODS FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE | 2006 |
|
RU2406529C2 |
MONOCLONAL BODY AGAINST AMYLOID BETA | 2008 |
|
RU2571856C2 |
ACTIVE IMMUNISATION FOR CREATING SOLUBLE A-BETA ANTIBODIES | 2004 |
|
RU2390350C2 |
IMMUNOGENIC PRODUCTS OBTAINED BASED ON AMINO ACID SEQUENCES OF MUTEIN AMYLOID β (Aβ) AND THEIR APPLICATION METHODS | 2015 |
|
RU2750268C2 |
THERAPEUTIC VACCINE | 2006 |
|
RU2440824C2 |
METHOD OF USE IN THERAPY | 2010 |
|
RU2579659C2 |
PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE | 2013 |
|
RU2696566C2 |
MONOCLONAL ANTIBODIES AND APPLICATIONS THEREOF | 2006 |
|
RU2432362C2 |
METHOD OF TREATING ALZHEIMER'S DISEASE | 2009 |
|
RU2526155C2 |
VACCINE AGAINST INTERMEDIATE WITH AMYLOID COAGULATION | 2009 |
|
RU2546234C2 |
Authors
Dates
2014-11-20—Published
2010-05-26—Filed